Insider Cluster (2 insiders) ·Filed Apr 1, 2026

PCVX

Vaxcyte, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed5mo ago
Insider cluster: 2 insiders, $262K total
Actionable Insight • Neutral

This level of selling is routine for a company of this size and not a material red flag. Traders should monitor for recurrence or larger divestitures, but no immediate action is warranted.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
PCVX ▼ -1.33% at T+60d
NEUTRAL call ✗ call lost -1.33% · α vs SPY -14.71% · entry $58.50 → $57.72
Entry anchored
Mar 31, 03:59 PM ET
via exchange tick
T+1d
-0.21%
call -0.21% · α -0.28%
$58.38
settled 6mo ago
T+5d
+5.45%
call +5.45% · α +1.69%
$61.69
settled 6mo ago
T+20d
-2.02%
call -2.02% · α -11.74%
$57.32
settled 5mo ago
T+60d
-1.33%
call -1.33% · α -14.71%
$57.72
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Two Vaxcyte executives sold shares in the past week, including COO Jim Wassil selling $82K and SVP Elvia selling $180K after exercising options. The total cluster value is $262K, representing 0.003% of market cap — a routine, modest-sized insider selling event.

Key Financial Metrics

Direction
selling
Total Value
$262.0K
Insiders
2

Key Facts

  • Chief Operating Officer Jim Wassil sold $82,000 worth of shares in an open-market transaction.
  • SVP and CAO Elvia Cowan sold $180,000 in shares, following the exercise of 6,000 derivative securities (3,000 exercised at $0, 3,000 at $25.92).
  • Total insider selling cluster value: $262,000 over a 7-day window.
  • No insider purchases or grants; net direction is selling.
  • Cluster represents only 0.003% of Vaxcyte's $8.7B market cap.

Financial Impact

$262,000 in open-market share sales over 7 days

insider ownershipfloat

Risk Factors

  • Perception of insider skepticism if selling continues in coming weeks
  • Potential for negative sentiment if no offsetting positive news emerges

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-PCVX-1775680392851
13 reports for PCVX
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for PCVX — sortable, filterable
TypeNow
Aug 5, 2026
8w ago
Insider Cluster
NEUTRAL ★ 2/10
$55.92 $61.58▲ +10.12%▲ +10.72%$56.69 (+1.38%)
Jul 6, 2026
12w ago
Insider Cluster
NEUTRAL ★ 2/10
$60.67 $53.53▼ −11.77%▼ −13.10%$56.69 (−6.56%)
Jul 6, 2026
12w ago
Insider Cluster
NEUTRAL ★ 2/10
$60.67 $53.53▼ −11.77%▼ −13.10%$56.69 (−6.56%)
Jun 26, 2026
13w ago
144
NEUTRAL ★ 3/10
$57.72 $54.66▼ −5.30%▼ −5.02%$56.69 (−1.78%)
Jun 23, 2026
14w ago
8-K
NEUTRAL ★ 2/10
$53.87 $56.00▲ +3.95%▲ +2.02%$56.69 (+5.23%)
Jun 19, 2026
15w ago
Insider Cluster
NEUTRAL ★ 3/10
$52.11 $56.20▲ +7.85%▲ +8.00%$56.69 (+8.79%)
Jun 2, 2026
17w ago
Press Release
NEUTRAL ★ 4/10
$46.93 $58.39▲ +24.42%▲ +25.42%$56.69 (+20.80%)
May 6, 2026
21w ago
8-K
BEARISH ★ 7/10
$51.48 $46.93▲ +8.84%▲ +11.97%$56.69 (−10.12%)
Apr 23, 2026
23w ago
DEFA14A
NEUTRAL ★ 3/10
$59.49 $47.39▼ −20.34%▼ −24.37%$56.69 (−4.71%)
Apr 1, 2026
26w ago
Insider Cluster
NEUTRAL ★ 3/10
$58.50 $57.32▼ −2.02%▼ −11.74%$56.69 (−3.09%)
Showing 10 of 13

US Market Status

Market Open — Closes in 3h 58m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Apr 8, 2026